Dian Diagnostics Group Co.,Ltd. (SZSE: 300244)
Health Care · Health Care Providers & Services · CN
CN¥20.52
-1.30% today · +25.1% 1Y
Dian Diagnostics Group Co.,Ltd. (SZSE: 300244) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.87B and employs 7,462 people.
Over the last twelve months the share price has gained 25.1%, trading between 14.48 and 33.30.
Tweenvest scores Dian Diagnostics Group Co.,Ltd. across four factors: quality 68/100, value 37/100, growth 20/100, dividend 58/100. Its strongest factor is quality.
300244 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.87B
- Revenue (TTM)
- $1.46B
- P/E
- 47.09
- EPS
- 0.44
- Dividend yield
- 1.71%
- Beta (5Y)
- 0.69
- 52-week high
- CN¥33.30
- 52-week low
- CN¥14.48
- Avg volume (3M)
- —
- Shares outstanding
- 611.10M
- Employees
- 7,462
- Next earnings
- —
About Dian Diagnostics Group Co.,Ltd.
Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.
- ISIN
- CNE1000015N1
- Founded
- 1996
- Listed since
- Jul 19, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Meheco Group Co., Ltd.SHSE: 600056 | $1.98B | CN¥8.88 | +0.23% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd.SHSE: 603882 | $1.98B | CN¥29.06 | -1.12% |
| Extendicare Inc.TSX: EXE | $1.89B | CA$27.20 | -3.85% |
| Huaxia Eye Hospital Group Co.,Ltd.SZSE: 301267 | $1.87B | CN¥15.06 | -0.66% |
| Astrana Health, Inc.NasdaqCM: ASTH | $1.84B | $35.87 | -3.42% |
| Fagron NVENXTBR: FAGR | $1.83B | €22.30 | -2.41% |
| Alignment Healthcare, Inc.NasdaqGS: ALHC | $1.81B | $8.71 | +1.87% |
| emeis Société anonymeENXTPA: EMEIS | $1.77B | €9.89 | +0.05% |
Figures last refreshed Oct 4, 2026.